BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 22418030)

  • 1. In vivo evaluation of 1-O-(4-(2-fluoroethyl-carbamoyloxymethyl)-2-nitrophenyl)-O-β-D-glucopyronuronate: a positron emission tomographic tracer for imaging β-glucuronidase activity in a tumor/inflammation rodent model.
    Antunes IF; Haisma HJ; Elsinga PH; van Waarde A; Willemsen AT; Dierckx RA; de Vries EF
    Mol Imaging; 2012 Feb; 11(1):77-87, E1. PubMed ID: 22418030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of [18F]-FEAnGA as a PET Tracer for beta-glucuronidase activity.
    Antunes IF; Haisma HJ; Elsinga PH; Dierckx RA; de Vries EF
    Bioconjug Chem; 2010 May; 21(5):911-20. PubMed ID: 20415436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of β-glucuronidase release by cytostatic agents in small tumors.
    Antunes IF; Haisma HJ; Elsinga PH; Di Gialleonardo V; van Waarde A; Willemsen AT; Dierckx RA; de Vries EF
    Mol Pharm; 2012 Nov; 9(11):3277-85. PubMed ID: 23009590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evaluation of [18F]FEAnGA-Me: a PET tracer for imaging β-glucuronidase (β-GUS) activity in a tumor/inflammation rodent model.
    Antunes IF; Haisma HJ; Elsinga PH; Sijbesma JW; Waarde Av; Willemsen AT; Dierckx RA; de Vries EF
    Nucl Med Biol; 2012 Aug; 39(6):854-63. PubMed ID: 22445742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FEAnGA for PET of β-glucuronidase activity in neuroinflammation.
    Antunes IF; Doorduin J; Haisma HJ; Elsinga PH; van Waarde A; Willemsen AT; Dierckx RA; de Vries EF
    J Nucl Med; 2012 Mar; 53(3):451-8. PubMed ID: 22323774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of [(11)C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat models of inflammation.
    de Vries EF; Doorduin J; Dierckx RA; van Waarde A
    Nucl Med Biol; 2008 Jan; 35(1):35-42. PubMed ID: 18158941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo.
    Heiss P; Mayer S; Herz M; Wester HJ; Schwaiger M; Senekowitsch-Schmidtke R
    J Nucl Med; 1999 Aug; 40(8):1367-73. PubMed ID: 10450690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [18F]FDG labeling of neural stem cells for in vivo cell tracking with positron emission tomography: inhibition of tracer release by phloretin.
    Stojanov K; de Vries EF; Hoekstra D; van Waarde A; Dierckx RA; Zuhorn IS
    Mol Imaging; 2012 Feb; 11(1):1-12. PubMed ID: 22418021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro evaluation of 18F labeled tyrosine derivatives as potential positron emission tomography (PET) imaging agents.
    Wang L; Qu W; Lieberman B; Ploessl K; Kung HF
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3482-5. PubMed ID: 20529679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of 18F- and 11C-labeled phenyl-galactopyranosides as potential probes for in vivo visualization of LacZ gene expression using positron emission tomography.
    Celen S; Deroose C; de Groot T; Chitneni SK; Gijsbers R; Debyser Z; Mortelmans L; Verbruggen A; Bormans G
    Bioconjug Chem; 2008 Feb; 19(2):441-9. PubMed ID: 18179161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.
    Beer AJ; Haubner R; Sarbia M; Goebel M; Luderschmidt S; Grosu AL; Schnell O; Niemeyer M; Kessler H; Wester HJ; Weber WA; Schwaiger M
    Clin Cancer Res; 2006 Jul; 12(13):3942-9. PubMed ID: 16818691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of 2'-deoxy-2'-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression.
    Alauddin MM; Shahinian A; Park R; Tohme M; Fissekis JD; Conti PS
    J Nucl Med; 2004 Dec; 45(12):2063-9. PubMed ID: 15585483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography.
    Yaghoubi SS; Barrio JR; Namavari M; Satyamurthy N; Phelps ME; Herschman HR; Gambhir SS
    Cancer Gene Ther; 2005 Mar; 12(3):329-39. PubMed ID: 15592447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
    Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
    J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Click synthesis and biologic evaluation of (R)- and (S)-2-amino-3-[1-(2-[18F]fluoroethyl)-1H-[1,2,3]triazol-4-yl]propanoic acid for brain tumor imaging with positron emission tomography.
    McConathy J; Zhou D; Shockley SE; Jones LA; Griffin EA; Lee H; Adams SJ; Mach RH
    Mol Imaging; 2010 Dec; 9(6):329-42. PubMed ID: 21084029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET imaging of β-glucuronidase activity by an activity-based 124I-trapping probe for the personalized glucuronide prodrug targeted therapy.
    Su YC; Cheng TC; Leu YL; Roffler SR; Wang JY; Chuang CH; Kao CH; Chen KC; Wang HE; Cheng TL
    Mol Cancer Ther; 2014 Dec; 13(12):2852-63. PubMed ID: 25277385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved radiosynthesis of O-(2-[
    Neumann KD; Thompson CM; Blecha JE; Gerdes JM; VanBrocklin HF
    J Labelled Comp Radiopharm; 2017 Jun; 60(7):337-342. PubMed ID: 28406525
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.